Global IVD Infectious Diseases Market Insights, Forecast to 2028

  • Report ID:236753
  • Industry Name: Medical Care
  • Publishing Date: Jun-22
  • No. of Pages: 119
                              
IVD Infectious Diseases market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global IVD Infectious Diseases market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028. Segment by Type Immunochemistry Molecular Diagnostics Segment by Application Clinical Laboratories Diagnostic Centers By Company BD BioMerieux Abbott Quidel Gen-Probe Abbott Danaher Sysmex Orasure Hologic Cepheid Qiagen Roche Diagnostics Siemens Healthcare Bio-Rad Laboratories By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA
                        
1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Immunochemistry 1.2.3 Molecular Diagnostics 1.3 Market by Application 1.3.1 Global IVD Infectious Diseases Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Clinical Laboratories 1.3.3 Diagnostic Centers 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global IVD Infectious Diseases Market Perspective (2017-2028) 2.2 IVD Infectious Diseases Growth Trends by Region 2.2.1 IVD Infectious Diseases Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 IVD Infectious Diseases Historic Market Size by Region (2017-2022) 2.2.3 IVD Infectious Diseases Forecasted Market Size by Region (2023-2028) 2.3 IVD Infectious Diseases Market Dynamics 2.3.1 IVD Infectious Diseases Industry Trends 2.3.2 IVD Infectious Diseases Market Drivers 2.3.3 IVD Infectious Diseases Market Challenges 2.3.4 IVD Infectious Diseases Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top IVD Infectious Diseases Players by Revenue 3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2017-2022) 3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2017-2022) 3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by IVD Infectious Diseases Revenue 3.4 Global IVD Infectious Diseases Market Concentration Ratio 3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2021 3.5 IVD Infectious Diseases Key Players Head office and Area Served 3.6 Key Players IVD Infectious Diseases Product Solution and Service 3.7 Date of Enter into IVD Infectious Diseases Market 3.8 Mergers & Acquisitions, Expansion Plans 4 IVD Infectious Diseases Breakdown Data by Type 4.1 Global IVD Infectious Diseases Historic Market Size by Type (2017-2022) 4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2023-2028) 5 IVD Infectious Diseases Breakdown Data by Application 5.1 Global IVD Infectious Diseases Historic Market Size by Application (2017-2022) 5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America IVD Infectious Diseases Market Size (2017-2028) 6.2 North America IVD Infectious Diseases Market Size by Type 6.2.1 North America IVD Infectious Diseases Market Size by Type (2017-2022) 6.2.2 North America IVD Infectious Diseases Market Size by Type (2023-2028) 6.2.3 North America IVD Infectious Diseases Market Share by Type (2017-2028) 6.3 North America IVD Infectious Diseases Market Size by Application 6.3.1 North America IVD Infectious Diseases Market Size by Application (2017-2022) 6.3.2 North America IVD Infectious Diseases Market Size by Application (2023-2028) 6.3.3 North America IVD Infectious Diseases Market Share by Application (2017-2028) 6.4 North America IVD Infectious Diseases Market Size by Country 6.4.1 North America IVD Infectious Diseases Market Size by Country (2017-2022) 6.4.2 North America IVD Infectious Diseases Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe IVD Infectious Diseases Market Size (2017-2028) 7.2 Europe IVD Infectious Diseases Market Size by Type 7.2.1 Europe IVD Infectious Diseases Market Size by Type (2017-2022) 7.2.2 Europe IVD Infectious Diseases Market Size by Type (2023-2028) 7.2.3 Europe IVD Infectious Diseases Market Share by Type (2017-2028) 7.3 Europe IVD Infectious Diseases Market Size by Application 7.3.1 Europe IVD Infectious Diseases Market Size by Application (2017-2022) 7.3.2 Europe IVD Infectious Diseases Market Size by Application (2023-2028) 7.3.3 Europe IVD Infectious Diseases Market Share by Application (2017-2028) 7.4 Europe IVD Infectious Diseases Market Size by Country 7.4.1 Europe IVD Infectious Diseases Market Size by Country (2017-2022) 7.4.2 Europe IVD Infectious Diseases Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific IVD Infectious Diseases Market Size (2017-2028) 8.2 Asia-Pacific IVD Infectious Diseases Market Size by Type 8.2.1 Asia-Pacific IVD Infectious Diseases Market Size by Type (2017-2022) 8.2.2 Asia-Pacific IVD Infectious Diseases Market Size by Type (2023-2028) 8.2.3 Asia-Pacific IVD Infectious Diseases Market Share by Type (2017-2028) 8.3 Asia-Pacific IVD Infectious Diseases Market Size by Application 8.3.1 Asia-Pacific IVD Infectious Diseases Market Size by Application (2017-2022) 8.3.2 Asia-Pacific IVD Infectious Diseases Market Size by Application (2023-2028) 8.3.3 Asia-Pacific IVD Infectious Diseases Market Share by Application (2017-2028) 8.4 Asia-Pacific IVD Infectious Diseases Market Size by Region 8.4.1 Asia-Pacific IVD Infectious Diseases Market Size by Region (2017-2022) 8.4.2 Asia-Pacific IVD Infectious Diseases Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America IVD Infectious Diseases Market Size (2017-2028) 9.2 Latin America IVD Infectious Diseases Market Size by Type 9.2.1 Latin America IVD Infectious Diseases Market Size by Type (2017-2022) 9.2.2 Latin America IVD Infectious Diseases Market Size by Type (2023-2028) 9.2.3 Latin America IVD Infectious Diseases Market Share by Type (2017-2028) 9.3 Latin America IVD Infectious Diseases Market Size by Application 9.3.1 Latin America IVD Infectious Diseases Market Size by Application (2017-2022) 9.3.2 Latin America IVD Infectious Diseases Market Size by Application (2023-2028) 9.3.3 Latin America IVD Infectious Diseases Market Share by Application (2017-2028) 9.4 Latin America IVD Infectious Diseases Market Size by Country 9.4.1 Latin America IVD Infectious Diseases Market Size by Country (2017-2022) 9.4.2 Latin America IVD Infectious Diseases Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa IVD Infectious Diseases Market Size (2017-2028) 10.2 Middle East & Africa IVD Infectious Diseases Market Size by Type 10.2.1 Middle East & Africa IVD Infectious Diseases Market Size by Type (2017-2022) 10.2.2 Middle East & Africa IVD Infectious Diseases Market Size by Type (2023-2028) 10.2.3 Middle East & Africa IVD Infectious Diseases Market Share by Type (2017-2028) 10.3 Middle East & Africa IVD Infectious Diseases Market Size by Application 10.3.1 Middle East & Africa IVD Infectious Diseases Market Size by Application (2017-2022) 10.3.2 Middle East & Africa IVD Infectious Diseases Market Size by Application (2023-2028) 10.3.3 Middle East & Africa IVD Infectious Diseases Market Share by Application (2017-2028) 10.4 Middle East & Africa IVD Infectious Diseases Market Size by Country 10.4.1 Middle East & Africa IVD Infectious Diseases Market Size by Country (2017-2022) 10.4.2 Middle East & Africa IVD Infectious Diseases Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 BD 11.1.1 BD Company Details 11.1.2 BD Business Overview 11.1.3 BD IVD Infectious Diseases Introduction 11.1.4 BD Revenue in IVD Infectious Diseases Business (2017-2022) 11.1.5 BD Recent Developments 11.2 BioMerieux 11.2.1 BioMerieux Company Details 11.2.2 BioMerieux Business Overview 11.2.3 BioMerieux IVD Infectious Diseases Introduction 11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2017-2022) 11.2.5 BioMerieux Recent Developments 11.3 Abbott 11.3.1 Abbott Company Details 11.3.2 Abbott Business Overview 11.3.3 Abbott IVD Infectious Diseases Introduction 11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2017-2022) 11.3.5 Abbott Recent Developments 11.4 Quidel 11.4.1 Quidel Company Details 11.4.2 Quidel Business Overview 11.4.3 Quidel IVD Infectious Diseases Introduction 11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2017-2022) 11.4.5 Quidel Recent Developments 11.5 Gen-Probe 11.5.1 Gen-Probe Company Details 11.5.2 Gen-Probe Business Overview 11.5.3 Gen-Probe IVD Infectious Diseases Introduction 11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2017-2022) 11.5.5 Gen-Probe Recent Developments 11.6 Abbott 11.6.1 Abbott Company Details 11.6.2 Abbott Business Overview 11.6.3 Abbott IVD Infectious Diseases Introduction 11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2017-2022) 11.6.5 Abbott Recent Developments 11.7 Danaher 11.7.1 Danaher Company Details 11.7.2 Danaher Business Overview 11.7.3 Danaher IVD Infectious Diseases Introduction 11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2017-2022) 11.7.5 Danaher Recent Developments 11.8 Sysmex 11.8.1 Sysmex Company Details 11.8.2 Sysmex Business Overview 11.8.3 Sysmex IVD Infectious Diseases Introduction 11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2017-2022) 11.8.5 Sysmex Recent Developments 11.9 Orasure 11.9.1 Orasure Company Details 11.9.2 Orasure Business Overview 11.9.3 Orasure IVD Infectious Diseases Introduction 11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2017-2022) 11.9.5 Orasure Recent Developments 11.10 Hologic 11.10.1 Hologic Company Details 11.10.2 Hologic Business Overview 11.10.3 Hologic IVD Infectious Diseases Introduction 11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2017-2022) 11.10.5 Hologic Recent Developments 11.11 Cepheid 11.11.1 Cepheid Company Details 11.11.2 Cepheid Business Overview 11.11.3 Cepheid IVD Infectious Diseases Introduction 11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2017-2022) 11.11.5 Cepheid Recent Developments 11.12 Qiagen 11.12.1 Qiagen Company Details 11.12.2 Qiagen Business Overview 11.12.3 Qiagen IVD Infectious Diseases Introduction 11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2017-2022) 11.12.5 Qiagen Recent Developments 11.13 Roche Diagnostics 11.13.1 Roche Diagnostics Company Details 11.13.2 Roche Diagnostics Business Overview 11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction 11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2017-2022) 11.13.5 Roche Diagnostics Recent Developments 11.14 Siemens Healthcare 11.14.1 Siemens Healthcare Company Details 11.14.2 Siemens Healthcare Business Overview 11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction 11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2017-2022) 11.14.5 Siemens Healthcare Recent Developments 11.15 Bio-Rad Laboratories 11.15.1 Bio-Rad Laboratories Company Details 11.15.2 Bio-Rad Laboratories Business Overview 11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction 11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2017-2022) 11.15.5 Bio-Rad Laboratories Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer
                
List of Tables Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Immunochemistry Table 3. Key Players of Molecular Diagnostics Table 4. Global IVD Infectious Diseases Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 5. Global IVD Infectious Diseases Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global IVD Infectious Diseases Market Size by Region (2017-2022) & (US$ Million) Table 7. Global IVD Infectious Diseases Market Share by Region (2017-2022) Table 8. Global IVD Infectious Diseases Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global IVD Infectious Diseases Market Share by Region (2023-2028) Table 10. IVD Infectious Diseases Market Trends Table 11. IVD Infectious Diseases Market Drivers Table 12. IVD Infectious Diseases Market Challenges Table 13. IVD Infectious Diseases Market Restraints Table 14. Global IVD Infectious Diseases Revenue by Players (2017-2022) & (US$ Million) Table 15. Global IVD Infectious Diseases Revenue Share by Players (2017-2022) Table 16. Global Top IVD Infectious Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2021) Table 17. Ranking of Global Top IVD Infectious Diseases Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players IVD Infectious Diseases Product Solution and Service Table 21. Date of Enter into IVD Infectious Diseases Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2017-2022) Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2023-2028) Table 27. Global IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 28. Global IVD Infectious Diseases Revenue Share by Application (2017-2022) Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global IVD Infectious Diseases Revenue Share by Application (2023-2028) Table 31. North America IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 32. North America IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 33. North America IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 34. North America IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 35. North America IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 36. North America IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 37. Europe IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 38. Europe IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 39. Europe IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 40. Europe IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 41. Europe IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 42. Europe IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 43. Asia Pacific IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 44. Asia Pacific IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 45. Asia Pacific IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 46. Asia Pacific IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 47. Asia Pacific IVD Infectious Diseases Market Size by Region (2017-2022) & (US$ Million) Table 48. Asia Pacific IVD Infectious Diseases Market Size by Region (2023-2028) & (US$ Million) Table 49. Latin America IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 50. Latin America IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 51. Latin America IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 52. Latin America IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 53. Latin America IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 54. Latin America IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 55. Middle East and Africa IVD Infectious Diseases Market Size by Type (2017-2022) & (US$ Million) Table 56. Middle East and Africa IVD Infectious Diseases Market Size by Type (2023-2028) & (US$ Million) Table 57. Middle East and Africa IVD Infectious Diseases Market Size by Application (2017-2022) & (US$ Million) Table 58. Middle East and Africa IVD Infectious Diseases Market Size by Application (2023-2028) & (US$ Million) Table 59. Middle East and Africa IVD Infectious Diseases Market Size by Country (2017-2022) & (US$ Million) Table 60. Middle East and Africa IVD Infectious Diseases Market Size by Country (2023-2028) & (US$ Million) Table 61. BD Company Details Table 62. BD Business Overview Table 63. BD IVD Infectious Diseases Product Table 64. BD Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 65. BD Recent Developments Table 66. BioMerieux Company Details Table 67. BioMerieux Business Overview Table 68. BioMerieux IVD Infectious Diseases Product Table 69. BioMerieux Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 70. BioMerieux Recent Developments Table 71. Abbott Company Details Table 72. Abbott Business Overview Table 73. Abbott IVD Infectious Diseases Product Table 74. Abbott Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 75. Abbott Recent Developments Table 76. Quidel Company Details Table 77. Quidel Business Overview Table 78. Quidel IVD Infectious Diseases Product Table 79. Quidel Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 80. Quidel Recent Developments Table 81. Gen-Probe Company Details Table 82. Gen-Probe Business Overview Table 83. Gen-Probe IVD Infectious Diseases Product Table 84. Gen-Probe Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 85. Gen-Probe Recent Developments Table 86. Abbott Company Details Table 87. Abbott Business Overview Table 88. Abbott IVD Infectious Diseases Product Table 89. Abbott Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 90. Abbott Recent Developments Table 91. Danaher Company Details Table 92. Danaher Business Overview Table 93. Danaher IVD Infectious Diseases Product Table 94. Danaher Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 95. Danaher Recent Developments Table 96. Sysmex Company Details Table 97. Sysmex Business Overview Table 98. Sysmex IVD Infectious Diseases Product Table 99. Sysmex Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 100. Sysmex Recent Developments Table 101. Orasure Company Details Table 102. Orasure Business Overview Table 103. Orasure IVD Infectious Diseases Product Table 104. Orasure Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 105. Orasure Recent Developments Table 106. Hologic Company Details Table 107. Hologic Business Overview Table 108. Hologic IVD Infectious Diseases Product Table 109. Hologic Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 110. Hologic Recent Developments Table 111. Cepheid Company Details Table 112. Cepheid Business Overview Table 113. Cepheid IVD Infectious Diseases Product Table 114. Cepheid Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 115. Cepheid Recent Developments Table 116. Qiagen Company Details Table 117. Qiagen Business Overview Table 118. Qiagen IVD Infectious Diseases Product Table 119. Qiagen Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 120. Qiagen Recent Developments Table 121. Roche Diagnostics Company Details Table 122. Roche Diagnostics Business Overview Table 123. Roche Diagnostics IVD Infectious Diseases Product Table 124. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 125. Roche Diagnostics Recent Developments Table 126. Siemens Healthcare Company Details Table 127. Siemens Healthcare Business Overview Table 128. Siemens Healthcare IVD Infectious Diseases Product Table 129. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 130. Siemens Healthcare Recent Developments Table 131. Bio-Rad Laboratories Company Details Table 132. Bio-Rad Laboratories Business Overview Table 133. Bio-Rad Laboratories IVD Infectious Diseases Product Table 134. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2017-2022) & (US$ Million) Table 135. Bio-Rad Laboratories Recent Developments Table 136. Research Programs/Design for This Report Table 137. Key Data Information from Secondary Sources Table 138. Key Data Information from Primary Sources List of Figures Figure 1. Global IVD Infectious Diseases Market Share by Type: 2021 VS 2028 Figure 2. Immunochemistry Features Figure 3. Molecular Diagnostics Features Figure 4. Global IVD Infectious Diseases Market Share by Application: 2021 VS 2028 Figure 5. Clinical Laboratories Case Studies Figure 6. Diagnostic Centers Case Studies Figure 7. IVD Infectious Diseases Report Years Considered Figure 8. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 9. Global IVD Infectious Diseases Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global IVD Infectious Diseases Market Share by Region: 2021 VS 2028 Figure 11. Global IVD Infectious Diseases Market Share by Players in 2021 Figure 12. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2021) Figure 13. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2021 Figure 14. North America IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 15. North America IVD Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 16. North America IVD Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 17. North America IVD Infectious Diseases Market Size Share by Country (2017-2028) Figure 18. United States IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 21. Europe IVD Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 22. Europe IVD Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 23. Europe IVD Infectious Diseases Market Size Share by Country (2017-2028) Figure 24. Germany IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. France IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. U.K. IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Italy IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Russia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Nordic Countries IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 31. Asia Pacific IVD Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 32. Asia Pacific IVD Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 33. Asia Pacific IVD Infectious Diseases Market Size Share by Region (2017-2028) Figure 34. China IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Japan IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. South Korea IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. India IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Australia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 40. Latin America IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 41. Latin America IVD Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 42. Latin America IVD Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 43. Latin America IVD Infectious Diseases Market Size Share by Country (2017-2028) Figure 44. Mexico IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Brazil IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 46. Middle East & Africa IVD Infectious Diseases Market Size YoY (2017-2028) & (US$ Million) Figure 47. Middle East and Africa IVD Infectious Diseases Market Size Market Share by Type (2017-2028) Figure 48. Middle East and Africa IVD Infectious Diseases Market Size Market Share by Application (2017-2028) Figure 49. Middle East and Africa IVD Infectious Diseases Market Size Share by Country (2017-2028) Figure 50. Turkey IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. UAE IVD Infectious Diseases Market Size YoY Growth (2017-2028) & (US$ Million) Figure 53. BD Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 54. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 55. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 56. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 57. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 58. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 59. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 60. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 61. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 62. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 63. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 64. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 65. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 66. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 67. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2017-2022) Figure 68. Bottom-up and Top-down Approaches for This Report Figure 69. Data Triangulation Figure 70. Key Executives Interviewed

Purchase Report

Single User 3480
Multi User 5250
Corporate User 6960
Buy

Purchase Report

Customize the purchase as per your specific research needs:

  • 20% additional customization
  • Request for country level reports
  • Request for historical statistics
  • Additional company profile on request

Why Choose Our Report?

24/5 Research support

Get your queries resolved from an industry expert

Custom research service

Design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.